首页 > 最新文献

ANZ Journal of Surgery最新文献

英文 中文
E-Scooter-Related Neurotrauma: A Modifiable Burden of Modern Mobility. 电动滑板车相关的神经创伤:现代交通的可改变负担。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2026-03-10 DOI: 10.1111/ans.70435
Peter Curpen, Virginia Newcombe, Ramon Navarro, Ming Lu, Fatima Nasrallah
{"title":"E-Scooter-Related Neurotrauma: A Modifiable Burden of Modern Mobility.","authors":"Peter Curpen, Virginia Newcombe, Ramon Navarro, Ming Lu, Fatima Nasrallah","doi":"10.1111/ans.70435","DOIUrl":"https://doi.org/10.1111/ans.70435","url":null,"abstract":"","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147430281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nonagenarians to Centenarians: A Case Series of Gastric Cancer Surgery in the Very Elderly. 九十岁至百岁:高龄胃癌手术病例系列。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2026-03-09 DOI: 10.1111/ans.70567
Masayuki Urabe, Masaya Hiyoshi, Toshiyuki Watanabe, Yojiro Hashiguchi
{"title":"Nonagenarians to Centenarians: A Case Series of Gastric Cancer Surgery in the Very Elderly.","authors":"Masayuki Urabe, Masaya Hiyoshi, Toshiyuki Watanabe, Yojiro Hashiguchi","doi":"10.1111/ans.70567","DOIUrl":"https://doi.org/10.1111/ans.70567","url":null,"abstract":"","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147375870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pelvic Exenteration: Oncological and Surgical Outcomes From a Single Tertiary Statewide Service. 盆腔切除:从单一三级全州服务的肿瘤和手术结果。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2026-03-09 DOI: 10.1111/ans.70547
Elena T Blyth, Michael R Lonne, Kandice B Keogh, Jane E Theodore, Craig A Harris

Background: Advancements in the multidisciplinary management of locally advanced and recurrent rectal cancer, as well as advanced pelvic malignancies, have significantly improved oncological outcomes. Pelvic exenteration is a complex procedure involving en bloc resection of the involved organs with the aim of achieving a microscopic negative margin (R0)1. Since 2012, the Royal Brisbane and Women's Hospital (RBWH) has been performing pelvic exenteration surgery and is now the statewide referral centre in Queensland. This study aims to present our oncological and surgical outcomes since establishment.

Methods: This is a retrospective cohort study utilising data collected from medical records of patients who underwent pelvic exenteration at the RBWH between 1 January 2012 and 31 August 2023. Ethics approval was obtained from the Metro North Hospital and Health Service Human Research Ethics Committee (HREC 102257).

Results: A total of 139 patients underwent pelvic exenteration surgery over the 11-year period. 117 of those were total exenteration, 22 were partial. The indications were locally advanced rectal cancer (56.8%), locally recurrent rectal cancer (22.3%), other primary or recurrent malignancy or benign, (10.8%, 7.9%, 2.2% respectively). The proportion of patients with an R0 resection was 90.4%. The overall survival (using Kaplan-Meier analysis) at 1, 2 and 5 years was 89.9%, 82.0%, and 62.9%, respectively. Disease-free survival at 1, 2 and 5 years was 76.1%, 67.0% and 59.2%. Disease-specific survival at 1, 2 and 5 years was 92.7%, 83.8% and 66.8%.

Conclusion: Our results were comparable to national data and PelvEx Collaborative group data and demonstrate that pelvic exenteration surgery can be safely performed in a lower volume centre with equivalent outcomes to higher volume centres.

背景:局部晚期和复发性直肠癌以及晚期盆腔恶性肿瘤的多学科治疗取得进展,显著改善了肿瘤预后。盆腔切除是一项复杂的手术,涉及到受累器官的整体切除,目的是实现显微镜下的阴性切缘(R0)1。自2012年以来,布里斯班皇家妇女医院(RBWH)一直在进行盆腔切除手术,现在是昆士兰州的全州转诊中心。本研究旨在介绍我们成立以来的肿瘤和手术结果。方法:这是一项回顾性队列研究,利用从2012年1月1日至2023年8月31日期间在RBWH接受盆腔切除术的患者的医疗记录收集的数据。获得了Metro North医院和卫生服务人类研究伦理委员会(HREC 102257)的伦理批准。结果:在11年的时间里,共有139例患者接受了盆腔切除手术。117例为完全切除,22例为部分切除。适应症为局部晚期直肠癌(56.8%)、局部复发直肠癌(22.3%)、其他原发或复发的恶性或良性肿瘤(10.8%、7.9%、2.2%)。R0切除的患者比例为90.4%。1年、2年和5年的总生存率(使用Kaplan-Meier分析)分别为89.9%、82.0%和62.9%。1年、2年和5年无病生存率分别为76.1%、67.0%和59.2%。1年、2年和5年疾病特异性生存率分别为92.7%、83.8%和66.8%。结论:我们的结果与国家数据和PelvEx协作组数据相当,并表明盆腔切除手术可以安全地在小容量中心进行,结果与大容量中心相同。
{"title":"Pelvic Exenteration: Oncological and Surgical Outcomes From a Single Tertiary Statewide Service.","authors":"Elena T Blyth, Michael R Lonne, Kandice B Keogh, Jane E Theodore, Craig A Harris","doi":"10.1111/ans.70547","DOIUrl":"https://doi.org/10.1111/ans.70547","url":null,"abstract":"<p><strong>Background: </strong>Advancements in the multidisciplinary management of locally advanced and recurrent rectal cancer, as well as advanced pelvic malignancies, have significantly improved oncological outcomes. Pelvic exenteration is a complex procedure involving en bloc resection of the involved organs with the aim of achieving a microscopic negative margin (R0)<sup>1</sup>. Since 2012, the Royal Brisbane and Women's Hospital (RBWH) has been performing pelvic exenteration surgery and is now the statewide referral centre in Queensland. This study aims to present our oncological and surgical outcomes since establishment.</p><p><strong>Methods: </strong>This is a retrospective cohort study utilising data collected from medical records of patients who underwent pelvic exenteration at the RBWH between 1 January 2012 and 31 August 2023. Ethics approval was obtained from the Metro North Hospital and Health Service Human Research Ethics Committee (HREC 102257).</p><p><strong>Results: </strong>A total of 139 patients underwent pelvic exenteration surgery over the 11-year period. 117 of those were total exenteration, 22 were partial. The indications were locally advanced rectal cancer (56.8%), locally recurrent rectal cancer (22.3%), other primary or recurrent malignancy or benign, (10.8%, 7.9%, 2.2% respectively). The proportion of patients with an R0 resection was 90.4%. The overall survival (using Kaplan-Meier analysis) at 1, 2 and 5 years was 89.9%, 82.0%, and 62.9%, respectively. Disease-free survival at 1, 2 and 5 years was 76.1%, 67.0% and 59.2%. Disease-specific survival at 1, 2 and 5 years was 92.7%, 83.8% and 66.8%.</p><p><strong>Conclusion: </strong>Our results were comparable to national data and PelvEx Collaborative group data and demonstrate that pelvic exenteration surgery can be safely performed in a lower volume centre with equivalent outcomes to higher volume centres.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147389217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Application of Progressive Suspension in Thoracoscopic Right Upper Lobectomy. 渐进式悬吊在胸腔镜右上肺叶切除术中的临床应用。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2026-03-09 DOI: 10.1111/ans.70549
Liankai Yang, Hao Hang, Bo Yang, Xiang Song, Fanyi Kong, Xiaoyun Bai, Hao Lu, Hongbo Guo

Objective: To compare the clinical efficacy of the progressive suspension method and conventional thoracoscopic pulmonary resection in right upper lobectomy.

Methods: A prospective cohort study was conducted involving 60 patients admitted to the Department of Thoracic Surgery at Cangzhou Central Hospital from January 2024 to March 2025. Patients were randomly divided into the observation group (n = 30, using the progressive suspension method, including 15 cases of trans-thoracic puncture fixation and 15 cases of intra-thoracic suture fixation) and the control group (n = 30, conventional thoracoscopic pulmonary resection). Surgical field exposure, operative fluency, lymph node dissection, perioperative indicators, and hospitalization costs were compared between the two groups.

Results: The observation group demonstrated significantly superior surgical field exposure (83.3% vs. 50.0%, p = 0.008) and operative fluency (73.3% vs. 33.3%, p = 0.002). The operative time [(87.5 ± 23.2) min vs. (112.4 ± 35.6) min, p < 0.001], intraoperative blood loss [50 (20, 50) mL vs. 80 (50, 120) mL, p < 0.001], postoperative drainage [150 (100, 200) mL vs. 250 (180, 300) mL, p = 0.003], VAS pain score [(3.2 ± 1.1) vs. (4.8 ± 1.5), p < 0.001], and hospitalization costs [(4.5 ± 0.8) vs. (5.2 ± 1.1) ten thousand yuan, p = 0.009] were all significantly better in the observation group. The number of lymph nodes dissected [(10.3 ± 3.1) vs. (8.5 ± 2.8), p = 0.021] showed a statistically significant difference, while the complete lymph node resection rate (93.3% vs. 80.0%, p = 0.143) and complication rate (16.7% vs. 33.3%, p = 0.132) showed no significant difference. No statistical differences were observed between the two suspension subgroups (p > 0.05).

Conclusion: The progressive suspension method in thoracoscopic right upper lobectomy provides superior surgical field exposure, improved operative fluency, higher surgical efficiency, and better postoperative recovery compared to the conventional method, making it a safe and effective surgical approach.

目的:比较渐进式悬吊法与常规胸腔镜肺切除术在右上肺叶切除术中的临床疗效。方法:对2024年1月至2025年3月沧州市中心医院胸外科收治的60例患者进行前瞻性队列研究。将患者随机分为观察组(n = 30,采用渐进式悬吊法,其中经胸穿刺固定15例,胸内缝合固定15例)和对照组(n = 30,采用常规胸腔镜肺切除术)。比较两组手术野暴露、手术流畅性、淋巴结清扫、围手术期指标及住院费用。结果:观察组患者手术野暴露(83.3%比50.0%,p = 0.008)和手术流畅性(73.3%比33.3%,p = 0.002)明显优于对照组。手术时间[(87.5±23.2)分钟和(112.4±35.6)分钟,p 0.05)。结论:胸腔镜右上肺叶切除术中渐进式悬吊法与常规方法相比,术野暴露好,手术流畅性好,手术效率高,术后恢复好,是一种安全有效的手术入路。
{"title":"Clinical Application of Progressive Suspension in Thoracoscopic Right Upper Lobectomy.","authors":"Liankai Yang, Hao Hang, Bo Yang, Xiang Song, Fanyi Kong, Xiaoyun Bai, Hao Lu, Hongbo Guo","doi":"10.1111/ans.70549","DOIUrl":"https://doi.org/10.1111/ans.70549","url":null,"abstract":"<p><strong>Objective: </strong>To compare the clinical efficacy of the progressive suspension method and conventional thoracoscopic pulmonary resection in right upper lobectomy.</p><p><strong>Methods: </strong>A prospective cohort study was conducted involving 60 patients admitted to the Department of Thoracic Surgery at Cangzhou Central Hospital from January 2024 to March 2025. Patients were randomly divided into the observation group (n = 30, using the progressive suspension method, including 15 cases of trans-thoracic puncture fixation and 15 cases of intra-thoracic suture fixation) and the control group (n = 30, conventional thoracoscopic pulmonary resection). Surgical field exposure, operative fluency, lymph node dissection, perioperative indicators, and hospitalization costs were compared between the two groups.</p><p><strong>Results: </strong>The observation group demonstrated significantly superior surgical field exposure (83.3% vs. 50.0%, p = 0.008) and operative fluency (73.3% vs. 33.3%, p = 0.002). The operative time [(87.5 ± 23.2) min vs. (112.4 ± 35.6) min, p < 0.001], intraoperative blood loss [50 (20, 50) mL vs. 80 (50, 120) mL, p < 0.001], postoperative drainage [150 (100, 200) mL vs. 250 (180, 300) mL, p = 0.003], VAS pain score [(3.2 ± 1.1) vs. (4.8 ± 1.5), p < 0.001], and hospitalization costs [(4.5 ± 0.8) vs. (5.2 ± 1.1) ten thousand yuan, p = 0.009] were all significantly better in the observation group. The number of lymph nodes dissected [(10.3 ± 3.1) vs. (8.5 ± 2.8), p = 0.021] showed a statistically significant difference, while the complete lymph node resection rate (93.3% vs. 80.0%, p = 0.143) and complication rate (16.7% vs. 33.3%, p = 0.132) showed no significant difference. No statistical differences were observed between the two suspension subgroups (p > 0.05).</p><p><strong>Conclusion: </strong>The progressive suspension method in thoracoscopic right upper lobectomy provides superior surgical field exposure, improved operative fluency, higher surgical efficiency, and better postoperative recovery compared to the conventional method, making it a safe and effective surgical approach.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147375791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oncological Outcomes After Margin-Negative (R0) Resection in Borderline Resectable Pancreatic Adenocarcinoma: Upfront Surgery Versus Neoadjuvant Treatment-A Contemporary Review. 交界性可切除胰腺腺癌边缘阴性(R0)切除后的肿瘤预后:前期手术与新辅助治疗——当代综述
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2026-03-09 DOI: 10.1111/ans.70575
Nan-Ak Wiboonkhwan

Background: Achieving a margin-negative (R0) resection in borderline resectable pancreatic cancer (BRPC) is a critical prognostic determinant. The optimal clinical strategy-neoadjuvant therapy (NAT) versus upfront surgery (UFS)-remains a key clinical question.

Methods: This narrative review synthesized contemporary evidence from studies published between 2009 and 2025, encompassing a total of 5598 patients with BRPC. The analysis compared oncological outcomes between NAT and UFS, specifically focusing on resection rates, R0 resection frequency, and median overall survival (OS). Mixed-cohort studies lacking BRPC subgroup analysis were excluded.

Results: Evidence from both comparative and single-arm studies indicated that the majority of cohorts achieved significantly higher R0 resection rates and improved median OS following NAT. Resection rates after NAT ranged from 29% to 90%, whereas UFS cohorts reported rates between 62% and 92%. Although resection was more frequent in UFS groups, NAT cohorts demonstrated superior oncological margins; R0 rates in NAT groups ranged from 23% to 100% compared to 14% to 90% in UFS groups. This translated into a survival benefit, with NAT groups achieving a median OS of 11.0 to 43.9 months versus 11.6 to 27.8 months for UFS. NAT also facilitated superior pathological downstaging and reduced lymph node positivity.

Conclusion: Neoadjuvant therapy, utilizing potent multi-agent regimens, significantly improves R0 resection rates and overall survival in BRPC and is increasingly recognized as the preferred clinical strategy. Currently, this survival benefit is not clearly established for patients with upfront resectable disease.

背景:边缘性可切除胰腺癌(BRPC)的边缘阴性(R0)切除是一个关键的预后决定因素。最佳的临床策略-新辅助治疗(NAT)与前期手术(UFS)-仍然是一个关键的临床问题。方法:本叙述性综述综合了2009年至2025年间发表的研究的当代证据,共包括5598例BRPC患者。该分析比较了NAT和UFS之间的肿瘤预后,特别关注切除率、R0切除频率和中位总生存期(OS)。排除了缺乏BRPC亚组分析的混合队列研究。结果:来自比较研究和单臂研究的证据表明,大多数队列在NAT后获得了显着更高的R0切除率和改善的中位OS。NAT后切除率从29%到90%不等,而UFS队列报告的发生率在62%到92%之间。虽然在UFS组中切除更频繁,但NAT组显示出更优越的肿瘤边缘;NAT组的R0率从23%到100%不等,而UFS组的R0率为14%到90%。这转化为生存优势,NAT组的中位OS为11.0至43.9个月,而UFS组的中位OS为11.6至27.8个月。NAT还促进了病理分期的降低和淋巴结阳性的降低。结论:采用有效的多药方案的新辅助治疗可显著提高BRPC的R0切除率和总生存率,并日益被认为是临床首选的治疗策略。目前,对于患有前期可切除疾病的患者,这种生存获益尚未明确确立。
{"title":"Oncological Outcomes After Margin-Negative (R0) Resection in Borderline Resectable Pancreatic Adenocarcinoma: Upfront Surgery Versus Neoadjuvant Treatment-A Contemporary Review.","authors":"Nan-Ak Wiboonkhwan","doi":"10.1111/ans.70575","DOIUrl":"https://doi.org/10.1111/ans.70575","url":null,"abstract":"<p><strong>Background: </strong>Achieving a margin-negative (R0) resection in borderline resectable pancreatic cancer (BRPC) is a critical prognostic determinant. The optimal clinical strategy-neoadjuvant therapy (NAT) versus upfront surgery (UFS)-remains a key clinical question.</p><p><strong>Methods: </strong>This narrative review synthesized contemporary evidence from studies published between 2009 and 2025, encompassing a total of 5598 patients with BRPC. The analysis compared oncological outcomes between NAT and UFS, specifically focusing on resection rates, R0 resection frequency, and median overall survival (OS). Mixed-cohort studies lacking BRPC subgroup analysis were excluded.</p><p><strong>Results: </strong>Evidence from both comparative and single-arm studies indicated that the majority of cohorts achieved significantly higher R0 resection rates and improved median OS following NAT. Resection rates after NAT ranged from 29% to 90%, whereas UFS cohorts reported rates between 62% and 92%. Although resection was more frequent in UFS groups, NAT cohorts demonstrated superior oncological margins; R0 rates in NAT groups ranged from 23% to 100% compared to 14% to 90% in UFS groups. This translated into a survival benefit, with NAT groups achieving a median OS of 11.0 to 43.9 months versus 11.6 to 27.8 months for UFS. NAT also facilitated superior pathological downstaging and reduced lymph node positivity.</p><p><strong>Conclusion: </strong>Neoadjuvant therapy, utilizing potent multi-agent regimens, significantly improves R0 resection rates and overall survival in BRPC and is increasingly recognized as the preferred clinical strategy. Currently, this survival benefit is not clearly established for patients with upfront resectable disease.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147389177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
16S rRNA Amplicon Sequencing of the Intraoperative Surgical Site Demonstrates an Aberrant Microbiota Which Can Predict Colorectal Surgical Site Infection. 术中手术部位16S rRNA扩增子测序显示异常微生物群可预测结直肠手术部位感染。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2026-03-09 DOI: 10.1111/ans.70578
Veral Vishnoi, Emily C Hoedt, Michelle Zhao, Rosemary Carroll, Shaveen Kanakaratne, Natalie Lott, Peter Pockney, Stephen R Smith, Simon Keely

Introduction: Surgical Site Infection (SSI) of an abdominal incision is a dreaded infectious complication following colorectal surgery. Understanding the intraoperative microbiology holds the key to prevention. Genomic sequencing has revolutionised culture-independent techniques, allowing for a more sensitive tool in microbial detection. The purpose of this study is to determine whether an aberrant microbiota is present within the intraoperative surgical site in patients that develop an SSI.

Methods: The subcutaneous abdominal surgical site of patients undergoing elective bowel resection was opportunistically sampled, following fascial closure. DNA was recovered from the swabs and used for 16S rRNA gene amplicon sequencing. The intraoperative microbiota was compared in those with and without a subsequent SSI with focus on alpha diversity and beta diversity, as well as taxonomic composition.

Results: 16/123 patients developed an SSI. The bacterial profile within the surgical site showed a strong presence of obligate anaerobes in all patients. Chao1, Shannon, and Simpson measures of alpha diversity from the intraoperative swabs were all significantly increased in SSI patients (p = 0.05, 0.05 and 0.05, respectively). Beta diversity demonstrated no significant separation between patients (Bray-Curtis dissimilarity index, PERMANOVA p = 0.394).

Conclusions: To the best of our knowledge this is the first study to demonstrate an aberrant intraoperative microbiota of the surgical site associated with subsequent infection. Pending validation studies, this provides a target for the strategic manipulation of the surgical site to reduce the burden of infection.

简介:腹部切口手术部位感染(SSI)是结直肠手术后一种可怕的感染性并发症。了解术中微生物学是预防的关键。基因组测序彻底改变了与培养无关的技术,使微生物检测工具更加灵敏。本研究的目的是确定发生SSI的患者术中手术部位是否存在异常微生物群。方法:择期肠切除术患者的皮下腹部手术部位在筋膜闭合后进行机会性取样。从拭子中提取DNA并用于16S rRNA基因扩增子测序。比较术后有SSI和无SSI患者术中微生物群,重点关注α多样性和β多样性,以及分类学组成。结果:123例患者中有16例发生SSI。手术部位的细菌谱显示,所有患者中均存在强专性厌氧菌。Chao1、Shannon和Simpson术中拭子α多样性测量值在SSI患者中均显著升高(p分别= 0.05、0.05和0.05)。β多样性在患者间无显著差异(Bray-Curtis dissimilarity index, PERMANOVA p = 0.394)。结论:据我们所知,这是第一个证明手术部位异常的术中微生物群与随后感染相关的研究。有待验证的研究,这为手术部位的战略性操作提供了一个目标,以减少感染的负担。
{"title":"16S rRNA Amplicon Sequencing of the Intraoperative Surgical Site Demonstrates an Aberrant Microbiota Which Can Predict Colorectal Surgical Site Infection.","authors":"Veral Vishnoi, Emily C Hoedt, Michelle Zhao, Rosemary Carroll, Shaveen Kanakaratne, Natalie Lott, Peter Pockney, Stephen R Smith, Simon Keely","doi":"10.1111/ans.70578","DOIUrl":"https://doi.org/10.1111/ans.70578","url":null,"abstract":"<p><strong>Introduction: </strong>Surgical Site Infection (SSI) of an abdominal incision is a dreaded infectious complication following colorectal surgery. Understanding the intraoperative microbiology holds the key to prevention. Genomic sequencing has revolutionised culture-independent techniques, allowing for a more sensitive tool in microbial detection. The purpose of this study is to determine whether an aberrant microbiota is present within the intraoperative surgical site in patients that develop an SSI.</p><p><strong>Methods: </strong>The subcutaneous abdominal surgical site of patients undergoing elective bowel resection was opportunistically sampled, following fascial closure. DNA was recovered from the swabs and used for 16S rRNA gene amplicon sequencing. The intraoperative microbiota was compared in those with and without a subsequent SSI with focus on alpha diversity and beta diversity, as well as taxonomic composition.</p><p><strong>Results: </strong>16/123 patients developed an SSI. The bacterial profile within the surgical site showed a strong presence of obligate anaerobes in all patients. Chao1, Shannon, and Simpson measures of alpha diversity from the intraoperative swabs were all significantly increased in SSI patients (p = 0.05, 0.05 and 0.05, respectively). Beta diversity demonstrated no significant separation between patients (Bray-Curtis dissimilarity index, PERMANOVA p = 0.394).</p><p><strong>Conclusions: </strong>To the best of our knowledge this is the first study to demonstrate an aberrant intraoperative microbiota of the surgical site associated with subsequent infection. Pending validation studies, this provides a target for the strategic manipulation of the surgical site to reduce the burden of infection.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147375862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to Do an Emergency Robotic Hartmann's Procedure in a Morbidly Obese Patient. 如何对病态肥胖患者实施紧急机器人哈特曼手术。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2026-03-08 DOI: 10.1111/ans.70563
Gavin J Carmichael, Yung-Hsin Hsueh, Daniel Ng Ying Kin, Kirk Underwood, Mathew O Jacob
{"title":"How to Do an Emergency Robotic Hartmann's Procedure in a Morbidly Obese Patient.","authors":"Gavin J Carmichael, Yung-Hsin Hsueh, Daniel Ng Ying Kin, Kirk Underwood, Mathew O Jacob","doi":"10.1111/ans.70563","DOIUrl":"https://doi.org/10.1111/ans.70563","url":null,"abstract":"","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147375776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extensor Indicis Proprius Transfers Versus Tendon Graft in Extensor Pollicis Longus Reconstruction: A Systematic Review and Meta-Analysis. 拇长伸肌重建中食指固有伸肌转移与肌腱移植:系统回顾和荟萃分析。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2026-03-08 DOI: 10.1111/ans.70558
Daniel J Keating, Simon J Maciburko, Pradyumna Herle, Anthony C Berger

Background: In extensor pollicis longus ruptures not amenable to primary repair, secondary reconstruction of the tendon has traditionally been performed using either extensor indicis transposition or free tendon graft techniques. This paper constitutes a systematic review and meta-analysis of the current literature with a focus on Geldmacher's scoring to identify the effectiveness of these procedures.

Methods: We performed a literature search of medical databases to identify papers fulfilling the inclusion criteria. A meta-analysis abiding by Preferred Reporting Items of Systematic Reviews and Meta-analyses was completed with Geldmacher's score as a primary outcome and objective measurement of functional recovery following each procedure.

Results: Nine papers were identified and included in the meta-analysis following independent review by three researchers. On analysis of the data, "very good" and "good" Geldmacher's scores were achieved in 81.8% of patients who underwent extensor indicis transfer and 87.5% of patients who underwent tendon grafting. These results suggest that both techniques represent an equivalent return to postoperative function.

Conclusions: This systematic review and meta-analysis found that both extensor indicis transfer and tendon graft provide a practically equivalent return to function following extensor pollicis longus reconstruction. However, clinical limitations of tendon grafting, along with theoretical models of tendon repair may suggest extensor indicis as a more reliable means of reconstruction.

背景:对于不能进行一次修复的拇长伸肌断裂,传统上采用指伸肌移位或自由肌腱移植技术进行肌腱的二次重建。本文对当前文献进行了系统回顾和荟萃分析,重点关注Geldmacher的评分,以确定这些程序的有效性。方法:我们对医学数据库进行文献检索,以确定符合纳入标准的论文。遵循系统评价和荟萃分析的首选报告项目,以Geldmacher评分作为主要结果和每个程序后功能恢复的客观测量来完成荟萃分析。结果:三名研究人员独立审查后,确定了九篇论文并将其纳入荟萃分析。通过对数据的分析,81.8%的指伸肌转移患者和87.5%的肌腱移植患者的Geldmacher评分达到“非常好”和“良好”。这些结果表明,这两种技术都代表了相同的术后功能恢复。结论:本系统综述和荟萃分析发现,在拇长伸肌重建后,食指伸肌转移和肌腱移植实际上都能提供相当的功能恢复。然而,肌腱移植的临床局限性以及肌腱修复的理论模型可能表明,指伸肌是一种更可靠的重建手段。
{"title":"Extensor Indicis Proprius Transfers Versus Tendon Graft in Extensor Pollicis Longus Reconstruction: A Systematic Review and Meta-Analysis.","authors":"Daniel J Keating, Simon J Maciburko, Pradyumna Herle, Anthony C Berger","doi":"10.1111/ans.70558","DOIUrl":"https://doi.org/10.1111/ans.70558","url":null,"abstract":"<p><strong>Background: </strong>In extensor pollicis longus ruptures not amenable to primary repair, secondary reconstruction of the tendon has traditionally been performed using either extensor indicis transposition or free tendon graft techniques. This paper constitutes a systematic review and meta-analysis of the current literature with a focus on Geldmacher's scoring to identify the effectiveness of these procedures.</p><p><strong>Methods: </strong>We performed a literature search of medical databases to identify papers fulfilling the inclusion criteria. A meta-analysis abiding by Preferred Reporting Items of Systematic Reviews and Meta-analyses was completed with Geldmacher's score as a primary outcome and objective measurement of functional recovery following each procedure.</p><p><strong>Results: </strong>Nine papers were identified and included in the meta-analysis following independent review by three researchers. On analysis of the data, \"very good\" and \"good\" Geldmacher's scores were achieved in 81.8% of patients who underwent extensor indicis transfer and 87.5% of patients who underwent tendon grafting. These results suggest that both techniques represent an equivalent return to postoperative function.</p><p><strong>Conclusions: </strong>This systematic review and meta-analysis found that both extensor indicis transfer and tendon graft provide a practically equivalent return to function following extensor pollicis longus reconstruction. However, clinical limitations of tendon grafting, along with theoretical models of tendon repair may suggest extensor indicis as a more reliable means of reconstruction.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147375865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of Endoscopic Retrograde Cholangiopancreatography (ERCP) for Choledocholithiasis in a Rural Australian Referral Centre: A 5-Year Retrospective Study. 澳大利亚农村转诊中心内窥镜逆行胆管造影(ERCP)治疗胆总管结石的结果:一项5年回顾性研究。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2026-03-06 DOI: 10.1111/ans.70574
Juanita Noeline Chui, Hye Rim Suh, Devansh Shah, Louis Britten-Jones, Lara Letuneca, Ramiz Iqbal, Daniel Breen, Geoffrey Chu, Henry Hook

Background: Endoscopic retrograde cholangiopancreatography (ERCP) is an essential therapeutic modality for the management of pancreatobiliary disease. Only two prior studies have reported ERCP outcomes in the rural Australian healthcare context. This study aimed to evaluate a 5-year experience of therapeutic ERCP for choledocholithiasis at a major rural referral centre in western New South Wales (NSW).

Methods: A retrospective cohort study was conducted including all patients who underwent ERCP for suspected choledocholithiasis at a rural NSW referral centre between January 2020 and January 2025. Data were collected on patient demographics, clinical presentation, procedural characteristics, cannulation failure and 30-day morbidity and mortality.

Results: Over the 5-year period, 1001 ERCP procedures were performed, of which 689 were for choledocholithiasis, treating 555 patients. Planned repeat ERCP for suspected incomplete duct clearance was required in 129 patients. Initial biliary cannulation failed in 11 patients, with successful repeat ERCP achieved in five within 72 h. Of the remaining six patients, one required percutaneous transhepatic cholangiography with anterograde stent placement, three had further intervention abandoned due to significant comorbidities and two were referred for SpyGlass cholangioscopy at a tertiary centre. Most procedures were performed emergently (81%) and 348 patients were transferred from peripheral hospitals. Median procedure time was 32 min and median length of stay was 2 days. ERCP-related complications occurred in 51 patients (9%), including post-ERCP pancreatitis (4%), post-sphincterotomy bleeding (3%), cholangitis (2%) and perforation (1%). Three ERCP-related deaths (0.4%) were recorded. Among emergency cases, median time to ERCP was shorter for local patients compared with transferred patients (1 vs. 4 days), with no difference in complication rates or 30-day mortality (p > 0.05).

Conclusions: This is one of the largest rural Australian ERCP series reported. Therapeutic ERCP for choledocholithiasis can be delivered safely and effectively in a rural setting, with outcomes comparable to tertiary centres.

背景:内镜逆行胰胆管造影(ERCP)是治疗胰胆管疾病的一种重要治疗方式。只有两个先前的研究报告了ERCP在澳大利亚农村医疗保健方面的结果。本研究旨在评估新南威尔士州西部一个主要农村转诊中心的5年治疗性ERCP治疗胆总管结石的经验。方法:回顾性队列研究包括2020年1月至2025年1月在新南威尔士州农村转诊中心因疑似胆总管结石接受ERCP治疗的所有患者。收集了患者人口统计学、临床表现、手术特点、插管失败和30天发病率和死亡率的数据。结果:在5年期间,进行了1001例ERCP手术,其中689例为胆总管结石,治疗了555例患者。129例疑似导管清除不完全的患者需要计划重复ERCP。11例患者初始胆道插管失败,5例患者在72小时内成功重复ERCP。其余6例患者中,1例需要经皮经肝胆管造影并顺行支架置入,3例因明显合并症而放弃进一步干预,2例转诊至三级中心接受SpyGlass胆管镜检查。大多数手术是紧急进行的(81%),348名患者是从周边医院转过来的。中位手术时间为32分钟,中位住院时间为2天。51例(9%)患者出现ercp相关并发症,包括ercp后胰腺炎(4%)、括约肌切开术后出血(3%)、胆管炎(2%)和穿孔(1%)。记录了3例ercp相关死亡(0.4%)。在急诊病例中,本地患者到ERCP的中位时间比转院患者短(1天比4天),并发症发生率和30天死亡率无差异(p < 0.05)。结论:这是澳大利亚农村最大的ERCP系列报道之一。治疗胆总管结石的ERCP可以在农村环境中安全有效地提供,其结果与三级中心相当。
{"title":"Outcomes of Endoscopic Retrograde Cholangiopancreatography (ERCP) for Choledocholithiasis in a Rural Australian Referral Centre: A 5-Year Retrospective Study.","authors":"Juanita Noeline Chui, Hye Rim Suh, Devansh Shah, Louis Britten-Jones, Lara Letuneca, Ramiz Iqbal, Daniel Breen, Geoffrey Chu, Henry Hook","doi":"10.1111/ans.70574","DOIUrl":"https://doi.org/10.1111/ans.70574","url":null,"abstract":"<p><strong>Background: </strong>Endoscopic retrograde cholangiopancreatography (ERCP) is an essential therapeutic modality for the management of pancreatobiliary disease. Only two prior studies have reported ERCP outcomes in the rural Australian healthcare context. This study aimed to evaluate a 5-year experience of therapeutic ERCP for choledocholithiasis at a major rural referral centre in western New South Wales (NSW).</p><p><strong>Methods: </strong>A retrospective cohort study was conducted including all patients who underwent ERCP for suspected choledocholithiasis at a rural NSW referral centre between January 2020 and January 2025. Data were collected on patient demographics, clinical presentation, procedural characteristics, cannulation failure and 30-day morbidity and mortality.</p><p><strong>Results: </strong>Over the 5-year period, 1001 ERCP procedures were performed, of which 689 were for choledocholithiasis, treating 555 patients. Planned repeat ERCP for suspected incomplete duct clearance was required in 129 patients. Initial biliary cannulation failed in 11 patients, with successful repeat ERCP achieved in five within 72 h. Of the remaining six patients, one required percutaneous transhepatic cholangiography with anterograde stent placement, three had further intervention abandoned due to significant comorbidities and two were referred for SpyGlass cholangioscopy at a tertiary centre. Most procedures were performed emergently (81%) and 348 patients were transferred from peripheral hospitals. Median procedure time was 32 min and median length of stay was 2 days. ERCP-related complications occurred in 51 patients (9%), including post-ERCP pancreatitis (4%), post-sphincterotomy bleeding (3%), cholangitis (2%) and perforation (1%). Three ERCP-related deaths (0.4%) were recorded. Among emergency cases, median time to ERCP was shorter for local patients compared with transferred patients (1 vs. 4 days), with no difference in complication rates or 30-day mortality (p > 0.05).</p><p><strong>Conclusions: </strong>This is one of the largest rural Australian ERCP series reported. Therapeutic ERCP for choledocholithiasis can be delivered safely and effectively in a rural setting, with outcomes comparable to tertiary centres.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147368878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trust, but Verify: An Exploratory Audit of Predatory Journal and Publisher Solicitations. 信任,但要验证:掠夺性期刊和出版商征稿的探索性审计。
IF 1.6 4区 医学 Q3 SURGERY Pub Date : 2026-03-06 DOI: 10.1111/ans.70568
Cheryl Fung, Basil Razi, Marnique Basto, Simon Bariol, Tania Hossack, Sriskanthan Baskaranathan, David Ende, Henry H Woo

Background: Predatory journals threaten academic integrity by exploiting open-access models for profit over scholarly quality. They employ aggressive solicitation tactics targeting vulnerable researchers. This study analyses 1 year of solicitation data to identify characteristic patterns and red flags, focusing on impact factor (IF) claims, indexing status and International Standard Serial Number (ISSN) presence, commonly used to create a facade of credibility.

Methods: A retrospective descriptive audit examined 422 email solicitations received by a single academic urologist between January 2023 and January 2024. Journals were identified as predatory based on Beall's list, the KSCIEN list, or multiple red flags. Data were extracted from journal websites and verified using PubMed, Journal Citation Reports (JCR) and SCImago. Descriptive analyses identified indicators associated with predatory practices.

Results: Over a12-month period, 422 emails were received from 196 unique journals representing 89 publishers. Ninety-four journals claimed IF, only two were verified by JCR and 14 by SCImago. Of these, 48 claimed IF < 2, 47 claimed IF ≥ 2, with the highest reported 6.705. Seven journals falsely claimed PubMed indexing, and 47 lacked an ISSN. Sixty-two journals listed addresses linked to unrelated businesses, 12 provided none and many used vague geographic identifiers. Concerningly, only 111 journals appeared on both Beall's and KSCIEN lists, while 51 were on neither despite clear predatory behaviour.

Conclusions: These findings reveal predatory journals' pervasive unethical practices, fake IFs, false indexing, misleading information, thus undermining scholarly publishing. These exploratory findings, highlight the importance of greater researcher vigilance and systemic action to safeguard research communication.

背景:掠夺性期刊利用开放获取模式谋取利润而非学术质量,从而威胁学术诚信。他们对脆弱的研究人员采取咄咄逼人的引诱策略。本研究分析了1年的招标数据,以识别特征模式和危险信号,重点关注影响因子(IF)声明、索引状态和国际标准序列号(ISSN)的存在,这些通常用于创造可信度的表象。方法:回顾性描述性审计检查了一位泌尿科医生在2023年1月至2024年1月间收到的422封电子邮件。根据Beall的列表、KSCIEN列表或多个危险信号,期刊被确定为掠夺性期刊。数据从期刊网站上提取,并使用PubMed、journal Citation Reports (JCR)和SCImago进行验证。描述性分析确定了与掠夺性行为相关的指标。结果:在12个月的时间里,我们收到了来自89家出版商的196种不同期刊的422封电子邮件。94份期刊发表了IF,只有2份得到了JCR的验证,14份得到了SCImago的验证。结论:这些发现揭示了掠夺性期刊普遍存在的不道德行为、虚假的IF、错误的索引、误导性的信息,从而破坏了学术出版。这些探索性的发现强调了提高研究人员的警惕和系统行动以保障研究交流的重要性。
{"title":"Trust, but Verify: An Exploratory Audit of Predatory Journal and Publisher Solicitations.","authors":"Cheryl Fung, Basil Razi, Marnique Basto, Simon Bariol, Tania Hossack, Sriskanthan Baskaranathan, David Ende, Henry H Woo","doi":"10.1111/ans.70568","DOIUrl":"https://doi.org/10.1111/ans.70568","url":null,"abstract":"<p><strong>Background: </strong>Predatory journals threaten academic integrity by exploiting open-access models for profit over scholarly quality. They employ aggressive solicitation tactics targeting vulnerable researchers. This study analyses 1 year of solicitation data to identify characteristic patterns and red flags, focusing on impact factor (IF) claims, indexing status and International Standard Serial Number (ISSN) presence, commonly used to create a facade of credibility.</p><p><strong>Methods: </strong>A retrospective descriptive audit examined 422 email solicitations received by a single academic urologist between January 2023 and January 2024. Journals were identified as predatory based on Beall's list, the KSCIEN list, or multiple red flags. Data were extracted from journal websites and verified using PubMed, Journal Citation Reports (JCR) and SCImago. Descriptive analyses identified indicators associated with predatory practices.</p><p><strong>Results: </strong>Over a12-month period, 422 emails were received from 196 unique journals representing 89 publishers. Ninety-four journals claimed IF, only two were verified by JCR and 14 by SCImago. Of these, 48 claimed IF < 2, 47 claimed IF ≥ 2, with the highest reported 6.705. Seven journals falsely claimed PubMed indexing, and 47 lacked an ISSN. Sixty-two journals listed addresses linked to unrelated businesses, 12 provided none and many used vague geographic identifiers. Concerningly, only 111 journals appeared on both Beall's and KSCIEN lists, while 51 were on neither despite clear predatory behaviour.</p><p><strong>Conclusions: </strong>These findings reveal predatory journals' pervasive unethical practices, fake IFs, false indexing, misleading information, thus undermining scholarly publishing. These exploratory findings, highlight the importance of greater researcher vigilance and systemic action to safeguard research communication.</p>","PeriodicalId":8158,"journal":{"name":"ANZ Journal of Surgery","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147368921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
ANZ Journal of Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1